JERUSALEM — As Israel navigates a precarious period of geopolitical instability, a profound psychological phenomenon has emerged...
Lina Hope
Baxter International, the Illinois-based medical technology giant, has officially turned the page on a tumultuous period of...
In the rapidly evolving landscape of human genetics, researchers have long grappled with a fundamental dichotomy: the...
In a significant development for oncology care, a Phase II clinical trial has unveiled a potential breakthrough...
For 47-year-old Shelly, the month of May 2024 began with the mundane rhythms of daily life. Married...
Executive Summary: A New Front in Viral Hemorrhagic Fever On May 17, 2026, the World Health Organization...
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
The Dawn of De-escalation: DAPHNe Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Care
Introduction: A New Era in Precision Oncology For decades, the prevailing philosophy in oncology was "more is...
NEW YORK — As the Jewish community prepares for the festival of Chanukah, a season synonymous with...
The journey through a breast cancer diagnosis is often described as stepping into a dark room without...
In a landmark study that underscores the transformative potential of artificial intelligence in clinical medicine, the American...
